Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RFS”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Study completedNCT00006230
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC 51
Not applicableLooking for participantsNCT07006467
What this trial is testing

Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery

Who this might be right for
Critical Limb Ischemia (CLI)
Stentit 10
Early research (Phase 1)Study completedNCT00113113
What this trial is testing

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

Who this might be right for
Tumors
Astex Pharmaceuticals, Inc. 54
Testing effectiveness (Phase 2)Study completedNCT00005826
What this trial is testing

Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 17
Not applicableWithdrawnNCT02837523
What this trial is testing

Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)

Who this might be right for
Renal Fanconi SyndromePhotophobiaHypophosphatemia
CENTOGENE GmbH Rostock
Not applicableLooking for participantsNCT06287541
What this trial is testing

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Not applicableEnded earlyNCT01079598
What this trial is testing

RFS (Radiofrequency Stylet) - Radiofrequency Perforator Vein Treatment Study

Who this might be right for
Venous Insufficiency
Medtronic Endovascular 8
Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Not applicableUnknownNCT01565486
What this trial is testing

Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System

Who this might be right for
Thyroid Cancer
Seoul St. Mary's Hospital 304
Not applicableUnknownNCT01327807
What this trial is testing

Cure Cystinosis International Registry

Who this might be right for
CystinosisNephropathic CystinosisRenal Fanconi Syndrome
Cystinosis Research Foundation 750
Testing effectiveness (Phase 2)UnknownNCT00005876
What this trial is testing

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

Who this might be right for
Esophageal CancerGastric Cancer
Astex Pharmaceuticals, Inc.
Post-approval studies (Phase 4)UnknownNCT03253250
What this trial is testing

The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection

Who this might be right for
Chronic Hepatitis bHepatic Carcinoma
Huashan Hospital 432
Not applicableLooking for participantsNCT07036731
What this trial is testing

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Large-scale testing (Phase 3)Ended earlyNCT00113256
What this trial is testing

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc. 39
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Testing effectiveness (Phase 2)Study completedNCT00005872
What this trial is testing

Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00005874
What this trial is testing

Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcomaSmall Intestine Cancer
Astex Pharmaceuticals, Inc.
Not applicableStudy completedNCT02829086
What this trial is testing

Evaluation of the Refugee Family Strengthening (RFS) Program

Who this might be right for
Health Behavior
US Committee for Refugees and Immigrants 5,365
Large-scale testing (Phase 3)Looking for participantsNCT06644937
What this trial is testing

Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhujiang Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07328828
What this trial is testing

Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence

Who this might be right for
RFS
Second Affiliated Hospital, School of Medicine, Zhejiang University 20
Load More Results